Related Experiment Videos
The bidirectional genetic causality between immunocyte phenotypes and dilated cardiomyopathy: A bidirectional
Wenshuai Feng1,2, Xindi Chang1, Qiaozhi Li1,2
1Cardiac Center, the First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, China.
Medicine
|July 18, 2026
Summary
This study found a two-way genetic link between immune cell traits and dilated cardiomyopathy (DCM). Certain immune cell phenotypes increase DCM risk, while others offer protection, highlighting a complex immune system interplay.
Area of Science:
- Immunology
- Cardiovascular Genetics
- Mendelian Randomization
Background:
- The precise role of immune cell phenotypes in the pathogenesis of dilated cardiomyopathy (DCM) remains unclear.
- Understanding the bidirectional relationship between immune cells and DCM is crucial for elucidating disease mechanisms.
Purpose of the Study:
- To investigate the causal relationships between 731 immunocyte phenotypes and DCM using a bidirectional two-sample Mendelian randomization approach.
- To identify specific immune cell traits that influence DCM risk and progression.
Main Methods:
- Utilized genome-wide association study summary statistics from European ancestry populations for DCM cases and controls, and for immunocyte phenotypes.
- Employed multiple Mendelian randomization methods including inverse variance weighted, MR-Egger, and median estimators.
- Conducted sensitivity analyses to ensure the robustness of the findings.
Main Results:
- Identified 14 immunocyte phenotypes as risk factors and 15 as protective factors for DCM.
- Reverse Mendelian randomization indicated that DCM occurrence may increase 17 immunocyte phenotypes and decrease 9.
- Specifically, CD28 on secreting regulatory T cells was found to mitigate DCM, and DCM progression reduced CD28 levels.
Conclusions:
- Confirmed a bidirectional genetic relationship between immunocyte phenotypes and DCM.
- Highlighted the intricate interplay between the immune system and the development and progression of dilated cardiomyopathy.
- Suggests potential therapeutic targets within immune cell modulation for DCM management.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Myocarditis I: Introduction
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...